AMLX
Amylyx Pharmaceuticals Inc
28.00$
+0.9%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Cash Flow
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| -0.19 | -0.65 | -1.29 | -2.70 | 0.17 | -2.46 | -1.30 | |
| 0.00 | 0.00 | 0.00 | 0.01 | 0.02 | 0.01 | 0.01 | |
| 0.00 | 0.00 | 0.05 | 0.33 | 0.53 | 0.48 | 0.29 | |
| -0.01 | 0.05 | 0.15 | 0.33 | – | – | – | |
| 0.06 | 0.05 | 0.08 | -0.02 | -0.94 | -0.67 | -0.01 | |
| 0.00 | 0.00 | 0.01 | 0.04 | 0.02 | 0.00 | 0.00 | |
| 0.00 | 0.00 | -0.80 | -3.59 | 1.32 | 1.11 | 0.15 | |
| – | – | – | 6.53 | -0.05 | – | – | |
| 0.01 | 0.30 | 0.45 | 0.00 | 0.00 | – | – | |
| 0.01 | 0.83 | 2.74 | 6.49 | 0.05 | 0.01 | 2.72 | |
| 0.05 | 0.18 | 0.64 | 0.19 | 1.54 | -1.35 | 1.57 | |
| -0.19 | -0.65 | -1.30 | -2.74 | 0.15 | -2.46 | -1.31 |
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.